The in Vitro Activity of Certain Antimalarials against Erythrocytic Forms of Plasmodium Gallinaceum

D. Jane Taylor National Institutes of Health, National Microbiological Institute, Bethesda 14, Maryland

Search for other papers by D. Jane Taylor in
Current site
Google Scholar
PubMed
Close
,
Edward S. Josephson National Institutes of Health, National Microbiological Institute, Bethesda 14, Maryland

Search for other papers by Edward S. Josephson in
Current site
Google Scholar
PubMed
Close
,
Joseph Greenberg National Institutes of Health, National Microbiological Institute, Bethesda 14, Maryland

Search for other papers by Joseph Greenberg in
Current site
Google Scholar
PubMed
Close
, and
G. Robert Coatney National Institutes of Health, National Microbiological Institute, Bethesda 14, Maryland

Search for other papers by G. Robert Coatney in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

A series of compounds was tested for antimalarial activity in vitro against the erythrocytic forms of Plasmodium gallinaceum. Chloroquine, quinacrine, quinine, and the naphthoquinone, SN 12,320, were active at concentrations approximating those found in the blood of adequately treated chicks. Pamaquine was relatively inactive in vitro, but when administered to chickens gave rise to active metabolic intermediates. Sulfadiazine, metachloridine, chlorguanide, and two of its metabolic intermediates from monkeys, a number of 2,4-diaminopyrimidines, and a 2,4-diaminopterin were relatively inactive in vitro.

Author Notes

Save